Key result
Bioactive molecules and phytoconstituents demonstrated potential therapeutic effects in chronic kidney disease models by targeting key inflammatory, oxidative stress, and fibrotic pathways.
Systematic Review
Preclinical evidence suggests various plant-derived biomolecules may modulate therapeutic targets in chronic kidney disease, though clinical validation is lacking.
Answers are grounded in this paper and cite their sources.
Phytoconstituents may target CKD pathways; hypothesis-generating and should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Myilsamy et al. (2026) conducted a systematic review in Chronic Kidney Disease. Biomolecules and Phytoconstituents was evaluated. Bioactive molecules and phytoconstituents demonstrated potential therapeutic effects in chronic kidney disease models by targeting key inflammatory, oxidative stress, and fibrotic pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: